Rebranding, M&A, and the Commercial Reset: Preserve momentum & alignment when business changes

Mergers, acquisitions, and rebranding initiatives are among the highest-consequence commercial moments a life science organization faces. This session is for leadership teams navigating organizational change who need to protect customer relationships, maintain sales continuity, and prevent the internal misalignment that turns a strategic opportunity into a credibility gap. Attendees will learn how to manage a rebrand or post M&A integration without losing the clarity that buyers depend on, how to sustain customer trust through periods of transition, and how to reframe organizational change as a competitive signal rather than a source of market uncertainty.

Who Should Attend
- Leaders in CROs
- Diagnostics
- Life science tools
- Medtech
- And transition-stage scientific organizations